efavirenz and Viremia

efavirenz has been researched along with Viremia in 30 studies

Research

Studies (30)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (3.33)	18.2507
2000's	14 (46.67)	29.6817
2010's	11 (36.67)	24.3611
2020's	4 (13.33)	2.80

Authors

Authors	Studies
Cogill, D; Decloedt, E; Gandhi, M; Jennings, L; Kellermann, T; Nkantsu, Z; Orrell, C; Spinelli, M; van Schalkwyk, M; van Zyl, G	2
Banturaki, G; Buzibye, A; Castelnuovo, B; Khoo, S; Kiragga, A; Lamorde, M; Matovu, J; Neary, M; Olagunju, A; Owen, A; Twinomuhwezi, E; Waitt, C; Wools-Kaloustian, K; Yiannoutsos, C	1
Butler, CC; Dorward, J; Drain, PK; Gandhi, M; Garrett, N; Govender, K; Hayward, G; Lessells, R; Moodley, P; Samsunder, N; Sookrajh, Y; Turner, P	1
Appiah, LT; Beloukas, A; Chadwick, D; Geretti, AM; Phillips, RO; Ruggiero, A; Sarfo, FS; Smith, C; Stockdale, AJ; Villa, G	1
Anderson, J; Beilman, GJ; Calisto, SP; Chipman, JG; David, C; Douek, DC; Fletcher, CV; Haase, AT; Helgeson, E; Hoskuldsson, T; Jasurda, J; Kityo, C; Nganou-Makamdop, K; Pearson, H; Perkey, K; Reilly, C; Reimann, T; Rothenberger, M; Schacker, TW; Schmidt, TE; Southern, P; Ssali, F; Wietgrefe, S	1
Allavena, C; André-Garnier, E; Baffoin, S; Billaud, E; Ferré, V; Raffi, F; Reliquet, V; Rodallec, A; Sécher, S	1
Domingo, P; Ribera, E	1
Bosch, RJ; Eron, JJ; Kuritzkes, DR; Taiwo, B; Vardhanabhuti, S	1
Hull, MW; Lima, VD; Montaner, JS; Richard Harrigan, P; Sierra-Madero, J; Singer, J; Wood, E; Wu, Z	1
Berhanu, R; Brennan, AT; Fox, MP; Long, L; Maskew, M; Sanne, I; Shearer, K	1
Garner, W; Kulkarni, R; Miller, MD; Porter, DP; White, KL	1
Pacios, E	1
Adamson, L; Cannavo, E; Deere, JD; Fromentin, E; Higgins, J; Luciw, PA; North, TW; Schinazi, RF; Villalobos, A	1
Calvez, V; Flandre, P; Fourati, S; Girard, PM; Haïm-Boukobza, S; Katlama, C; Lavignon, M; Marcelin, AG; Morand-Joubert, L; Sayon, S; Simon, A; Valin, N	1
Boima, V; Flanigan, TP; Kenu, E; Kwara, A; Lartey, M; Mingle, JA; Oliver-Commey, J; Sagoe, A; Sagoe, KW; Seshie, M; Wu, H; Xexemeku, F; Yang, H	1
Bon, I; Borderi, M; Furlini, G; Gibellini, D; La Placa, M; Monari, P; Re, MC; Schiavone, P; Vitone, F	1
Brault, C; Chennebault, JM; Loison, J; Payan, C; Peigne, M	1
Clerici, M; Ferrante, P; Havlir, DV; Ignacio, C; Strain, MC; Trabattoni, D; Wong, JK	1
Boeri, E; Castagna, A; Gallotta, G; Gianotti, N; Maillard, M; Ratti, D; Serra, G; Tremolada, Y; Vacchini, D	1
Havlir, DV; Ignacio, CC; Koelsch, KK; Lu, B; Margot, N; Miller, MD; Strain, MC; Wong, JK	1
Dalmau, D; Ferrer, E; Gatell, JM; Iniguez, D; Knobel, H; Leon, A; Niubo, J; Podzamczer, D; Polo, C; Ruiz, I	1
Calvez, V; Deleuze, J; Dupin, N; Gorin, I; Krivine, A; Marcelin, AG; Martinez, V; Morini, JP; Perrin, L; Peytavin, G; Yerly, S	1
Amel, EB; Amel, LO; Amine, SM; Asma, J; Fethi, T; Mohamed, C; Mounira, G; Taoufik, BC	1
Bertelsen, L; Jakobsen, MR; Laursen, A; Mohey, R; Obel, N; Ostergaard, L; Tolstrup, M	1
Ansari, AW; Heiken, H; Schmidt, RE	1
Boyle, BA; Goldenberg, D	1
Bernard-Henry, C; Cheneau, C; de Mautort, E; Hess-Kempf, G; Krantz, V; Lang, JM; Partisani, M; Priester, M; Rey, D; Schmitt, MP	1
Belohradsky, BH; Eberle, J; Engelhorn, C; Funk, M; Hoffmann, F; Notheis, G; Wintergerst, U	1

Reviews

1 review(s) available for efavirenz and Viremia

Article	Year
[Data on rilpivirine in treatment-naïve patients. Lessons from ECHO, THRIVE and STaR]. Enfermedades infecciosas y microbiologia clinica, 2013, Volume: 31 Suppl 2 Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclopropanes; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Male; Medication Adherence; Multicenter Studies as Topic; Nitriles; Pyrimidines; Reverse Transcriptase Inhibitors; Rilpivirine; Therapeutic Equivalency; Treatment Outcome; Viral Load; Viremia	2013

Article

Year

[Data on rilpivirine in treatment-naïve patients. Lessons from ECHO, THRIVE and STaR].

Enfermedades infecciosas y microbiologia clinica, 2013, Volume: 31 Suppl 2

Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclopropanes; Drug Resistance, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Male; Medication Adherence; Multicenter Studies as Topic; Nitriles; Pyrimidines; Reverse Transcriptase Inhibitors; Rilpivirine; Therapeutic Equivalency; Treatment Outcome; Viral Load; Viremia

2013

Trials

6 trial(s) available for efavirenz and Viremia

Article	Year
Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy-years. Journal of the International AIDS Society, 2014, Volume: 17 Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Female; HIV Infections; HIV-1; Humans; Lopinavir; Male; Treatment Outcome; Viral Load; Viremia	2014
Viral blips were infrequent in treatment-naive adults treated with rilpivirine/emtricitabine/tenofovir DF or efavirenz/emtricitabine/tenofovir DF through 96 weeks. Antiviral therapy, 2017, Volume: 22, Issue:6 Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Resistance, Viral; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Male; Rilpivirine; RNA, Viral; Time Factors; Treatment Outcome; Viral Load; Viremia	2017
Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years. Journal of virology, 2003, Volume: 77, Issue:20 Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; DNA, Viral; HIV-1; Humans; Indinavir; Longitudinal Studies; Oxazines; RNA, Viral; Time Factors; Viremia	2003
Early virological failure with a combination of tenofovir, didanosine and efavirenz. Antiviral therapy, 2005, Volume: 10, Issue:1 Topics: Adenine; Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Didanosine; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Lopinavir; Male; Middle Aged; Mutation; Organophosphonates; Oxazines; Pyrimidinones; RNA, Viral; Tenofovir; Time Factors; Treatment Failure; Viremia	2005
Effects on immunological and virological outcome of patients using one protease inhibitor or one non-nucleoside reverse transcriptase inhibitor in a triple antiretroviral therapy: normal clinical practice versus clinical trial findings. Current HIV research, 2005, Volume: 3, Issue:3 Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Cohort Studies; Cyclopropanes; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Male; Oxazines; Retrospective Studies; Treatment Outcome; Tunisia; Viremia; Zidovudine	2005
Efavirenz as a substitute for protease inhibitors in HIV-1-infected patients with undetectable plasma viral load on HAART: a median follow-up of 64 weeks. Journal of acquired immune deficiency syndromes (1999), 2001, Aug-15, Volume: 27, Issue:5 Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cohort Studies; Cyclopropanes; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Middle Aged; Oxazines; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Viremia	2001

Other Studies

23 other study(ies) available for efavirenz and Viremia

Article	Year
Drug Resistance, Rather than Low Tenofovir Levels in Blood or Urine, Is Associated with Tenofovir, Emtricitabine, and Efavirenz Failure in Resource-Limited Settings. AIDS research and human retroviruses, 2022, Volume: 38, Issue:6 Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cross-Sectional Studies; Cyclopropanes; Drug Resistance; Emtricitabine; HIV Infections; Humans; South Africa; Tenofovir; Viral Load; Viremia	2022
Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens. AIDS (London, England), 2022, 11-15, Volume: 36, Issue:14 Topics: Anti-HIV Agents; Cross-Sectional Studies; HIV Infections; Humans; Protease Inhibitors; Ritonavir; Tenofovir; Viral Load; Viremia	2022
Relating CYP2B6 genotype and efavirenz resistance among post-partum women living with HIV with high viremia in Uganda: a nested cross-sectional study. AIDS research and therapy, 2023, 03-31, Volume: 20, Issue:1 Topics: Anti-HIV Agents; Benzoxazines; Cross-Sectional Studies; Cytochrome P-450 CYP2B6; Female; Genotype; HIV Infections; Humans; Polymorphism, Single Nucleotide; Postpartum Period; Pregnancy; Uganda; Viremia	2023
Diagnostic accuracy of a point-of-care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz-based antiretroviral therapy. Journal of the International AIDS Society, 2023, Volume: 26, Issue:9 Topics: Adult; Benzoxazines; Chromatography, Liquid; Cross-Sectional Studies; Female; HIV Infections; Humans; Male; Point-of-Care Systems; Tandem Mass Spectrometry; Tenofovir; Viremia	2023
Drug resistance outcomes of long-term ART with tenofovir disoproxil fumarate in the absence of virological monitoring. The Journal of antimicrobial chemotherapy, 2018, 11-01, Volume: 73, Issue:11 Topics: Adult; Africa South of the Sahara; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Mutation; Reverse Transcriptase Inhibitors; Tenofovir; Time Factors; Treatment Outcome; Viral Load; Viremia	2018
Impact of Integrase Inhibition Compared With Nonnucleoside Inhibition on HIV Reservoirs in Lymphoid Tissues. Journal of acquired immune deficiency syndromes (1999), 2019, 07-01, Volume: 81, Issue:3 Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Dendritic Cells, Follicular; Female; HIV Infections; HIV Integrase Inhibitors; Humans; In Situ Hybridization; Lymph Nodes; Lymphoid Tissue; Male; Raltegravir Potassium; Viral Load; Viremia; Young Adult	2019
Evaluation of residual viremia and quantitation of soluble CD14 in a large cohort of HIV-infected adults on a long-term non-nucleoside reverse transcriptase inhibitor-based regimen. Journal of medical virology, 2013, Volume: 85, Issue:11 Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cohort Studies; Cross-Sectional Studies; Cyclopropanes; Enzyme-Linked Immunosorbent Assay; Female; HIV Infections; HIV-1; Humans; Lipopolysaccharide Receptors; Male; Middle Aged; Monocytes; Nevirapine; Reverse Transcriptase Inhibitors; Viral Load; Viremia	2013
Phylogenetic evidence of HIV-1 sequence evolution in subjects with persistent low-level viraemia. Antiviral therapy, 2015, Volume: 20, Issue:1 Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Resistance, Viral; Evolution, Molecular; Female; HIV Infections; HIV-1; Humans; Lopinavir; Male; Middle Aged; Mutation; Phylogeny; pol Gene Products, Human Immunodeficiency Virus; Retrospective Studies; Ritonavir; RNA, Viral; Viral Load; Viremia	2015
The relation between efavirenz versus nevirapine and virologic failure in Johannesburg, South Africa. Journal of the International AIDS Society, 2014, Volume: 17 Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Female; Follow-Up Studies; HIV; HIV Infections; Humans; Male; Middle Aged; Nevirapine; South Africa; Treatment Failure; Viremia; Young Adult	2014
[Regimen simplification: lopinavir/ritonavir with or without efavirenz]. Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:9 Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; HIV Infections; Humans; Lopinavir; Pyrimidinones; Ritonavir; Treatment Outcome; Viral Load; Viremia	2009
Viral decay kinetics in the highly active antiretroviral therapy-treated rhesus macaque model of AIDS. PloS one, 2010, Jul-23, Volume: 5, Issue:7 Topics: Alkynes; Animals; Antiretroviral Therapy, Highly Active; Benzoxazines; Chromatography, High Pressure Liquid; Cyclopropanes; HIV Reverse Transcriptase; HIV-1; Macaca; Macaca mulatta; Reverse Transcriptase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Viremia	2010
Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml. AIDS (London, England), 2011, Jan-28, Volume: 25, Issue:3 Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Nevirapine; Retrospective Studies; Viral Load; Viremia	2011
Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an Efavirenz-based regimen. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Feb-15, Volume: 52, Issue:4 Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Benzoxazines; Cyclopropanes; Female; HIV; HIV Infections; Humans; Male; Tuberculosis; Viral Load; Viremia	2011
Development of drug resistance in HIV-1 patients receiving a combination of stavudine, lamivudine and efavirenz. International journal of antimicrobial agents, 2002, Volume: 20, Issue:3 Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Resistance, Viral; Genes, Viral; HIV Infections; HIV-1; Humans; Lamivudine; Mutation; Oxazines; RNA, Viral; Stavudine; Viral Load; Viremia	2002
[Measuring the HIV viral load with LCx (Abbott): importance for the therapeutic follow-up of 3 patients infected by type O HIV]. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2003, Volume: 10, Issue:2 Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Resistance, Multiple, Viral; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Oxazines; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Viral Load; Viremia; Zidovudine	2003
In vivo dynamics of the 103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in HIV-infected patients: preliminary results. The new microbiologica, 2004, Volume: 27, Issue:2 Suppl 1 Topics: Alkynes; Amino Acid Substitution; Base Sequence; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Delavirdine; DNA, Complementary; Drug Resistance, Viral; HIV; HIV Infections; HIV Reverse Transcriptase; Humans; Mutation; Nevirapine; Oxazines; Reverse Transcriptase Inhibitors; RNA, Viral; Selection, Genetic; Viremia	2004
Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudine. The Journal of infectious diseases, 2005, Apr-01, Volume: 191, Issue:7 Topics: Adenine; Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; DNA, Viral; Female; HIV; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Multivariate Analysis; Organophosphonates; Oxazines; RNA, Viral; Stavudine; Tenofovir; Viremia	2005
HIV-1 intermittent viraemia in patients treated by non-nucleoside reverse transcriptase inhibitor-based regimen. AIDS (London, England), 2005, Jul-01, Volume: 19, Issue:10 Topics: Adult; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Female; HIV Infections; HIV Reverse Transcriptase; Humans; Male; Middle Aged; Nevirapine; Oxazines; Retrospective Studies; Reverse Transcriptase Inhibitors; Viral Load; Viremia	2005
Dynamics of 103K/N and 184M/V HIV-1 drug resistant populations: relative comparison in plasma virus RNA versus CD45RO+T cell proviral DNA. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2007, Volume: 39, Issue:3 Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Leukocyte Common Antigens; Mutation; Nevirapine; Nucleic Acid Amplification Techniques; Proviruses; Reverse Transcriptase Inhibitors; RNA, Viral; T-Lymphocytes; Viremia	2007
Prednisolone mediated suppression of HIV-1 viral load strongly correlates with C-C chemokine CCL2: In vivo and in vitro findings. Clinical immunology (Orlando, Fla.), 2007, Volume: 125, Issue:1 Topics: Alkynes; Anti-HIV Agents; Anti-Inflammatory Agents; Benzoxazines; Chemokine CCL2; Cyclopropanes; Drug Resistance, Viral; Flow Cytometry; Gene Expression; HIV Infections; HIV-1; Humans; In Vitro Techniques; Interleukin-8; Lamivudine; Male; Prednisolone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha; Uveitis; Viral Load; Viremia; Zidovudine	2007
[HIV infection: DuPont Pharma presents the results of its antiretroviral agent]. Allergie et immunologie, 1998, Volume: 30, Issue:4 Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Evaluation; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Lamivudine; Oxazines; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Viremia; Zidovudine	1998
Current issues in antiretroviral and psychiatric therapy for HIV-infected patients. The AIDS reader, 2000, Volume: 10, Issue:9 Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; HIV Infections; Humans; Mental Disorders; Oxazines; Pneumonia, Pneumocystis; Viremia	2000
Effect of antiretroviral combination therapies including efavirenz in heavily pretreated HIV-infected children. European journal of medical research, 2002, Jan-29, Volume: 7, Issue:1 Topics: Adolescent; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Child; Child, Preschool; Cyclopropanes; Female; HIV Infections; HIV Protease Inhibitors; Humans; Male; Nelfinavir; Oxazines; Reverse Transcriptase Inhibitors; RNA, Viral; Viremia	2002